Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Valent

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Blood Cancer Journal|August 23, 2024
Disparities in time to treatment with oral antimyeloma medicationsHamlet Gasoyan, Faiz Anwer, Jeffrey D Kovach, et al.
American Journal of Ophthalmology|June 12, 2018
Ocular Adnexal Amyloidosis: A Mass Spectrometric AnalysisAlexander D Blandford, Sari Yordi, Saloni Kapoor, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 8, 2020
Daratumumab-based Regimen in Treating Clonal Plasma Cell Neoplasms in Solid Organ Transplant RecipientsChakra P Chaulagain, Julia M Diacovo, Leah Elson, et al.
Blood Cells, Molecules & Diseases|July 19, 2021
Monoclonal IgM gammopathy in adult acquired pure red cell aplasia: culprit or innocent bystander?Carmelo Gurnari, Simona Pagliuca, Hassan Awada, et al.
JACC. Case Reports|June 27, 2025
Primary Cardiac Lymphoma Masquerading as a Pericardial Mass: Imaging, 3D Printing, and Surgical ManagementJoseph Hajj, Serge C Harb, Ryan S Klatte, et al.
Blood Cancer Journal|June 26, 2021
Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapyRajshekhar Chakraborty, Lisa Rybicki, Jason Valent, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 9, 2023
Clinical Efficacy of Retreatment With Venetoclax-Based Therapy in Relapsed-Refractory t(11;14) Multiple MyelomaDanai Dima, Mark Orland, Fauzia Ullah, et al.
Blood Cancer Journal|December 20, 2024
Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance studyMajid Jaberi-Douraki, Xuan Xu, Danai Dima, et al.
British Journal of Haematology|February 29, 2020
Characterisation and prognostic impact of immunoparesis in relapsed multiple myelomaRajshekhar Chakraborty, Lisa Rybicki, Megan O Nakashima, et al.
Cancers|April 13, 2023
Management of Relapsed-Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical PracticeDanai Dima, Fauzia Ullah, Sandra Mazzoni, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Blood Cancer Journal|August 23, 2024
Disparities in time to treatment with oral antimyeloma medicationsHamlet Gasoyan, Faiz Anwer, Jeffrey D Kovach, et al.
American Journal of Ophthalmology|June 12, 2018
Ocular Adnexal Amyloidosis: A Mass Spectrometric AnalysisAlexander D Blandford, Sari Yordi, Saloni Kapoor, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 8, 2020
Daratumumab-based Regimen in Treating Clonal Plasma Cell Neoplasms in Solid Organ Transplant RecipientsChakra P Chaulagain, Julia M Diacovo, Leah Elson, et al.
Blood Cells, Molecules & Diseases|July 19, 2021
Monoclonal IgM gammopathy in adult acquired pure red cell aplasia: culprit or innocent bystander?Carmelo Gurnari, Simona Pagliuca, Hassan Awada, et al.
JACC. Case Reports|June 27, 2025
Primary Cardiac Lymphoma Masquerading as a Pericardial Mass: Imaging, 3D Printing, and Surgical ManagementJoseph Hajj, Serge C Harb, Ryan S Klatte, et al.
Blood Cancer Journal|June 26, 2021
Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapyRajshekhar Chakraborty, Lisa Rybicki, Jason Valent, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 9, 2023
Clinical Efficacy of Retreatment With Venetoclax-Based Therapy in Relapsed-Refractory t(11;14) Multiple MyelomaDanai Dima, Mark Orland, Fauzia Ullah, et al.
Blood Cancer Journal|December 20, 2024
Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance studyMajid Jaberi-Douraki, Xuan Xu, Danai Dima, et al.
British Journal of Haematology|February 29, 2020
Characterisation and prognostic impact of immunoparesis in relapsed multiple myelomaRajshekhar Chakraborty, Lisa Rybicki, Megan O Nakashima, et al.
Cancers|April 13, 2023
Management of Relapsed-Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical PracticeDanai Dima, Fauzia Ullah, Sandra Mazzoni, et al.
Pageof 9